Human pancreatic epithelial progenitor cells and methods of isolation and use thereof

A technology of progenitor cells and islet cells, applied in the fields of developmental biology and cell biology, can solve problems such as inability to accurately reflect the physiological parameters of pancreatic cells

Inactive Publication Date: 2003-06-18
RAVEN BIOTECHNOLOGIES INC
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, culturing pancreatic cells in serum does not accurately reflect the physiological parameters in which pancreatic cells exist in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
  • Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
  • Human pancreatic epithelial progenitor cells and methods of isolation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Embodiment 1

[0075] Examples Example 1: Isolation of pancreatic progenitor cells

[0076] Fetal pancreas (gestational age 14-22 weeks) was dissected mechanically by microdissection under a stereomicroscope, followed by enzymatic dissociation. Enzyme treatment included placing partially dissociated tissues in 1 ml of F12 / DMEM medium containing 5 mg / ml collagenase-dispase, 20 μg / ml soybean trypsin inhibitor, and 50 μg / ml DNase, and incubated at 37°C for 15 minute.

[0077] insulin

[0078] Dispense the resuspended cell aggregates into fibronectin-coated wells (6-12) of a 24-well plate and store in a humidified 37 °C, 5% CO 2 Incubate for 72 hours in an incubator. After 72 hours, epithelial cells formed suspended spherical structures ( figure 1 A), while mesenchymal or stromal cells adhere to the well walls. When a monolayer structure is desired, collect 6 wells of pancreatic aggregates or spheres with a micropipette and place in a collagen-coated 60 mm Pe...

Embodiment 2

[0078] Dispense the resuspended cell aggregates into fibronectin-coated wells (6-12) of a 24-well plate and store in a humidified 37 °C, 5% CO 2 Incubate for 72 hours in an incubator. After 72 hours, epithelial cells formed suspended spherical structures ( figure 1 A), while mesenchymal or stromal cells adhere to the well walls. When a monolayer structure is desired, collect 6 wells of pancreatic aggregates or spheres with a micropipette and place in a collagen-coated 60 mm Petri dish using F12 / DMEM as the basic nutrient medium and supplemented with this article Disclosed Nutrients. Within 24 hours, the above-mentioned structures adhered and cells from the above-mentioned structures spread out on the collagen to form an epithelial monolayer ( figure 1 B). These pancreatic progenitor cells can be passaged at least three times ( figure 2 ). Example 2: Use of pancreatic progenitor cells in transplantation

[0079] For the purpose of recombinant transplantation, cells were...

Embodiment 3

[0083] After transplanting pancreatic spheres into the subrenal membrane of mice and maintaining them at the site for 6-8 weeks, the grafts were harvested and analyzed to identify pancreatic cells by immunohistochemistry and function. showed that the grafts expressed insulin and glucagon ( Figure 4 , 5 , and 7). In addition, tissue grafted recombinants were shown to form ductal structures ( Figure 6 ). Thus, the tissue-reconstituted graft produces functional pancreatic cells capable of expressing insulin and glucagon and forming ductal structures.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a substantially pure population of human pancreatic progenitor cells and methods of isolating and culturing the pancreatic progenitor cells. By carefully manipulating the microenvironment of the pancreatic progenitor cells, multiple passages are attainable wherein the pancreatic progenitor cells do not senesce and furthermore, are capable of becoming functional exocrine or endocrine cells. In addition, several methods of use of human pancreatic progenitor cells are disclosed herein.

Description

field of invention [0001] The present invention belongs to the fields of developmental biology and cell biology. In particular, the invention relates to populations of pancreatic epithelial progenitor cells capable of differentiating into functional exocrine and endocrine cells, methods of isolating pancreatic epithelial progenitor cells, characterization of pancreatic epithelial progenitor cells, and uses of pancreatic epithelial progenitor cells. technical background [0002] Due to their enormous potential, stem and progenitor cells are isolated and characterized as the subject of intense research. Totipotent stem cells, capable of becoming any cell type in the human body, give rise to more differentiated progenitor cells than totipotent cells. One of these progenitor cell types is the predetermined pancreatic epithelial progenitor cell. Pancreatic epithelial progenitor cells can become different types of pancreatic epithelial cells, including acin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/02A61K35/12A61K35/39A61K39/00A61P3/10C12N5/02C12N5/071C12N5/074
CPCC12N2500/25C12N2501/392C12N2500/99A61K2035/122C12N2501/39C12N2501/395C12N5/0678A61K2035/126C12N2501/11A61K35/12C12N2501/60A61K2039/515C12N2500/90A61P1/18A61P3/10C12N5/0602
Inventor P·E·罗伯特兹J·P·马瑟
Owner RAVEN BIOTECHNOLOGIES INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products